Loading…
Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell
Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs...
Saved in:
Published in: | Analytical biochemistry 2018-07, Vol.553, p.1-6 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313 |
---|---|
cites | cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313 |
container_end_page | 6 |
container_issue | |
container_start_page | 1 |
container_title | Analytical biochemistry |
container_volume | 553 |
creator | Ma, Chengyao Li, Yue Wu, Hanqing Ji, Junyang Sun, Qianqian Song, Yilin Wang, Shen Li, Xiang Chen, Yong Chen, Jianwei |
description | Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p 1) were identified, and 5 pathways (impact-value > 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism.
[Display omitted]
•A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated. |
doi_str_mv | 10.1016/j.ab.2018.04.022 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2038273751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000326971830188X</els_id><sourcerecordid>2038273751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0EoreFPSvkJZuEcZw_s0NVoUhFbGBtjZ1J66vEvtgOUp-Bl8bRLexYzWLO-TRnDmNvBNQCRP_-WKOpGxBjDW0NTfOMHQSovgIJ6jk7AICsml4NF-wypSOAEG3Xv2QXjRo6UK08sN9fKaMJS1idTRw9Lo_JJR5mnh-In0Imnx0uZZOdRW8p8pXsA3qX1l2F3gePlsJW3JZyuCfvfAF4jnzdluymuN3zSIWaC4SvuK4YHzlO5IPFaJ0PK3JLy_KKvZhxSfT6aV6xH59uvl_fVnffPn-5_nhXWdlBrqxqAY2wwrRWqs4qHGgy4zwaiSXh2Cs7oBU0ChjkbIaOzDDj0LadadUohbxi787cUww_N0pZry7tB6Dfc-gG5NgMcuh2KZylNoaUIs36FN1-vxag9wr0UaPRewUaWl0qKJa3T_TNrDT9M_z9eRF8OAuoZPzlKOpkHZXXTi6SzXoK7v_0P75kmY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038273751</pqid></control><display><type>article</type><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><source>ScienceDirect Journals</source><creator>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</creator><creatorcontrib>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</creatorcontrib><description>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p < 0.05, VIP >1) were identified, and 5 pathways (impact-value > 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism.
[Display omitted]
•A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</description><identifier>ISSN: 0003-2697</identifier><identifier>EISSN: 1096-0309</identifier><identifier>DOI: 10.1016/j.ab.2018.04.022</identifier><identifier>PMID: 29750943</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetogenins - pharmacology ; Adenocarcinoma - pathology ; Animals ; Annonaceous acetogenins ; Arginine - metabolism ; Cell Line, Tumor ; Drug Resistance, Multiple ; Drug Resistance, Neoplasm ; Glycerophospholipids - metabolism ; Humans ; Mammary adenocarcinoma ; Mammary Neoplasms, Animal - pathology ; Metabolomics ; Multidrug resistance ; Proline - metabolism</subject><ispartof>Analytical biochemistry, 2018-07, Vol.553, p.1-6</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</citedby><cites>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29750943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Chengyao</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Wu, Hanqing</creatorcontrib><creatorcontrib>Ji, Junyang</creatorcontrib><creatorcontrib>Sun, Qianqian</creatorcontrib><creatorcontrib>Song, Yilin</creatorcontrib><creatorcontrib>Wang, Shen</creatorcontrib><creatorcontrib>Li, Xiang</creatorcontrib><creatorcontrib>Chen, Yong</creatorcontrib><creatorcontrib>Chen, Jianwei</creatorcontrib><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><title>Analytical biochemistry</title><addtitle>Anal Biochem</addtitle><description>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p < 0.05, VIP >1) were identified, and 5 pathways (impact-value > 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism.
[Display omitted]
•A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</description><subject>Acetogenins - pharmacology</subject><subject>Adenocarcinoma - pathology</subject><subject>Animals</subject><subject>Annonaceous acetogenins</subject><subject>Arginine - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Drug Resistance, Multiple</subject><subject>Drug Resistance, Neoplasm</subject><subject>Glycerophospholipids - metabolism</subject><subject>Humans</subject><subject>Mammary adenocarcinoma</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Metabolomics</subject><subject>Multidrug resistance</subject><subject>Proline - metabolism</subject><issn>0003-2697</issn><issn>1096-0309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0EoreFPSvkJZuEcZw_s0NVoUhFbGBtjZ1J66vEvtgOUp-Bl8bRLexYzWLO-TRnDmNvBNQCRP_-WKOpGxBjDW0NTfOMHQSovgIJ6jk7AICsml4NF-wypSOAEG3Xv2QXjRo6UK08sN9fKaMJS1idTRw9Lo_JJR5mnh-In0Imnx0uZZOdRW8p8pXsA3qX1l2F3gePlsJW3JZyuCfvfAF4jnzdluymuN3zSIWaC4SvuK4YHzlO5IPFaJ0PK3JLy_KKvZhxSfT6aV6xH59uvl_fVnffPn-5_nhXWdlBrqxqAY2wwrRWqs4qHGgy4zwaiSXh2Cs7oBU0ChjkbIaOzDDj0LadadUohbxi787cUww_N0pZry7tB6Dfc-gG5NgMcuh2KZylNoaUIs36FN1-vxag9wr0UaPRewUaWl0qKJa3T_TNrDT9M_z9eRF8OAuoZPzlKOpkHZXXTi6SzXoK7v_0P75kmY8</recordid><startdate>20180715</startdate><enddate>20180715</enddate><creator>Ma, Chengyao</creator><creator>Li, Yue</creator><creator>Wu, Hanqing</creator><creator>Ji, Junyang</creator><creator>Sun, Qianqian</creator><creator>Song, Yilin</creator><creator>Wang, Shen</creator><creator>Li, Xiang</creator><creator>Chen, Yong</creator><creator>Chen, Jianwei</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180715</creationdate><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><author>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acetogenins - pharmacology</topic><topic>Adenocarcinoma - pathology</topic><topic>Animals</topic><topic>Annonaceous acetogenins</topic><topic>Arginine - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Drug Resistance, Multiple</topic><topic>Drug Resistance, Neoplasm</topic><topic>Glycerophospholipids - metabolism</topic><topic>Humans</topic><topic>Mammary adenocarcinoma</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Metabolomics</topic><topic>Multidrug resistance</topic><topic>Proline - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Chengyao</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Wu, Hanqing</creatorcontrib><creatorcontrib>Ji, Junyang</creatorcontrib><creatorcontrib>Sun, Qianqian</creatorcontrib><creatorcontrib>Song, Yilin</creatorcontrib><creatorcontrib>Wang, Shen</creatorcontrib><creatorcontrib>Li, Xiang</creatorcontrib><creatorcontrib>Chen, Yong</creatorcontrib><creatorcontrib>Chen, Jianwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Analytical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Chengyao</au><au>Li, Yue</au><au>Wu, Hanqing</au><au>Ji, Junyang</au><au>Sun, Qianqian</au><au>Song, Yilin</au><au>Wang, Shen</au><au>Li, Xiang</au><au>Chen, Yong</au><au>Chen, Jianwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</atitle><jtitle>Analytical biochemistry</jtitle><addtitle>Anal Biochem</addtitle><date>2018-07-15</date><risdate>2018</risdate><volume>553</volume><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0003-2697</issn><eissn>1096-0309</eissn><abstract>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p < 0.05, VIP >1) were identified, and 5 pathways (impact-value > 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism.
[Display omitted]
•A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29750943</pmid><doi>10.1016/j.ab.2018.04.022</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2697 |
ispartof | Analytical biochemistry, 2018-07, Vol.553, p.1-6 |
issn | 0003-2697 1096-0309 |
language | eng |
recordid | cdi_proquest_miscellaneous_2038273751 |
source | ScienceDirect Journals |
subjects | Acetogenins - pharmacology Adenocarcinoma - pathology Animals Annonaceous acetogenins Arginine - metabolism Cell Line, Tumor Drug Resistance, Multiple Drug Resistance, Neoplasm Glycerophospholipids - metabolism Humans Mammary adenocarcinoma Mammary Neoplasms, Animal - pathology Metabolomics Multidrug resistance Proline - metabolism |
title | Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T14%3A06%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolomics%20analysis%20of%20the%20potential%20anticancer%20mechanism%20of%20annonaceous%20acetogenins%20on%20a%20multidrug%20resistant%20mammary%20adenocarcinoma%20cell&rft.jtitle=Analytical%20biochemistry&rft.au=Ma,%20Chengyao&rft.date=2018-07-15&rft.volume=553&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0003-2697&rft.eissn=1096-0309&rft_id=info:doi/10.1016/j.ab.2018.04.022&rft_dat=%3Cproquest_cross%3E2038273751%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2038273751&rft_id=info:pmid/29750943&rfr_iscdi=true |